Vandenbossche B - Search Results

1

18 F-Fluorodeoxyglucose triple-headed coincidence detection imaging in oncology: preliminary results and comparison with dedicated PET.

De Winter F, Van de Wiele C, Vandenberghe S, Vandenbossche B, D'Asseler Y, Huglo D, Dierckx R. De Winter F, et al. Among authors: vandenbossche b. Med Sci Monit. 2002 Jun;8(6):MT89-94. Med Sci Monit. 2002. PMID: 12070445

2

18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients.

Van Den Bossche B, Lambert B, De Winter F, Kolindou A, Dierckx RA, Noens L, Van De Wiele C. Van Den Bossche B, et al. Nucl Med Commun. 2002 Nov;23(11):1079-83. doi: 10.1097/00006231-200211000-00007. Nucl Med Commun. 2002. PMID: 12411836 Clinical Trial.

3

Receptor imaging in oncology by means of nuclear medicine: current status.

Van Den Bossche B, Van de Wiele C. Van Den Bossche B, et al. J Clin Oncol. 2004 Sep 1;22(17):3593-607. doi: 10.1200/JCO.2004.10.216. J Clin Oncol. 2004. PMID: 15337810 Review.

4

99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer.

Van Den Bossche B, D'haeninck E, De Winter F, Van Belle S, Dierckx RA, Van De Wiele C. Van Den Bossche B, et al. Nucl Med Commun. 2004 Aug;25(8):787-92. doi: 10.1097/01.mnm.0000134934.87929.84. Nucl Med Commun. 2004. PMID: 15266172 Clinical Trial.

5

A review of small animal imaging planar and pinhole spect Gamma camera imaging.

Peremans K, Cornelissen B, Van Den Bossche B, Audenaert K, Van de Wiele C. Peremans K, et al. Vet Radiol Ultrasound. 2005 Mar-Apr;46(2):162-70. doi: 10.1111/j.1740-8261.2005.00031.x. Vet Radiol Ultrasound. 2005. PMID: 15869162 Review.

6

Leakage assessment in adjustable laparoscopic gastric banding: radiography versus (99m)Tc-pertechnetate scintigraphy.

Van Den Bossche B, Goethals I, Dierckx RA, Villeirs G, Pattyn P, Van de Wiele C. Van Den Bossche B, et al. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1128-31. doi: 10.1007/s00259-002-0825-2. Epub 2002 Jun 15. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192556

7

Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.

Van Den Bossche B, D'haeninck E, Bacher K, Thierens H, Van Belle S, Dierckx RA, Van de Wiele C. Van Den Bossche B, et al. Cancer Biother Radiopharm. 2004 Dec;19(6):776-83. doi: 10.1089/cbr.2004.19.776. Cancer Biother Radiopharm. 2004. PMID: 15665627

8

Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.

Van Den Bossche B, Van Belle S, De Winter F, Signore A, Van de Wiele C. Van Den Bossche B, et al. J Nucl Med. 2006 Jan;47(1):6-13. J Nucl Med. 2006. PMID: 16391181 Free article. Clinical Trial.

9

Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients.

Rottey S, Van den Bossche B, Slegers G, Van Belle S, van de Wiele C. Rottey S, et al. Q J Nucl Med Mol Imaging. 2009 Apr;53(2):127-32. Epub 2008 Nov 28. Q J Nucl Med Mol Imaging. 2009. PMID: 19039304 Clinical Trial.

10

Oestrogen-mediated regulation of somatostatin receptor expression in human breast cancer cell lines assessed with 99mTc-depreotide.

Van Den Bossche B, D'haeninck E, De Vos F, Dierckx RA, Van Belle S, Bracke M, Van de Wiele C. Van Den Bossche B, et al. Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):1022-30. doi: 10.1007/s00259-004-1500-6. Epub 2004 Mar 17. Eur J Nucl Med Mol Imaging. 2004. PMID: 15029461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters